News Image

Molecular Partners Announces Participation at Upcoming Investor Conferences and 2024 Financial Results Conference Call

Provided By GlobeNewswire

Last update: Feb 28, 2025

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced its attendance and presentations at upcoming investor conferences.

Read more at globenewswire.com

MOLECULAR PARTNERS AG -ADR

NASDAQ:MOLN (7/25/2025, 8:07:47 PM)

After market: 3.6 -0.27 (-6.94%)

3.8685

-0.13 (-3.29%)



Find more stocks in the Stock Screener

Follow ChartMill for more